LAMB2 and muscular dystrophy: SSPN is able to reduce the pathology of muscular dystrophy in the DMD murine model by increasing membrane localization of the UGC and α7β1D-integrin adhesion complexes, effectively increasing laminin binding to compensate for the loss of dystrophin [25, 27–31].